Previous close | 31.00 |
Open | 32.14 |
Bid | 22.00 |
Ask | 31.50 |
Strike | 370.00 |
Expiry date | 2025-01-17 |
Day's range | 31.00 - 34.90 |
Contract range | N/A |
Volume | |
Open interest | 103 |
These time-tested businesses have the sustainable cash flow and catalysts needed to outperform when the U.S. economy isn't at its best.
If you're worried about how the banking sector turmoil will impact your investments, let me help ease your mind. As a result, investors who own renewable energy stocks shouldn't have anything to worry about. You can invest in Brookfield Renewable in a couple of ways.
Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Exelixis (NASDAQ: EXEL), and Intellia Therapeutics (NASDAQ: NTLA). Prosper Junior Bakiny (CRISPR Therapeutics): Unprofitable clinical-stage biotech companies got hammered last year. Gene-editing specialist CRISPR Therapeutics fits that description to a T, so it got dragged down along with the broader market.